Skip to content

Author

N. V. Gottumukkala

We have 1 of 6 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

Genome-wide CRISPR Screening Reveals Cullin-1 as a Therapeutic Target Enhancing Efficacy of CD19-directed Immunotherapy

C Cullin-1 inhibition stabilizes CD19 surface expression, preventing its loss under immunotherapeutic pressure and improving the efficiency of CD19-targeting immunotherapies, thus arguing for potential incorporation of pevonedistat into novel combination therapies.

N. V. Gottumukkala, Tomáš Loja, M. Šmída · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.